Journey Medical (DERM) Change in Accured Expenses (2020 - 2026)
Journey Medical (DERM) posted Change in Accured Expenses of -$8000.0 for Q1 2026, up 99.79% on a QoQ basis from -$3.8 million in Q4 2025, and down 100.14% year-over-year from $5.6 million in Q1 2025.
Journey Medical (DERM) Change in Accured Expenses (2020 - 2026) Analysis & Trends
Journey Medical's Change in Accured Expenses history runs 7 years deep, the most recent figure standing at -$8000.0 for Q1 2026.
- Quarterly Change in Accured Expenses fell 100.14% year-over-year to -$8000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.6 million (down 329.32% YoY) and the FY2025 annual result came in at -$6000.0, up 99.79% from the prior year.
- Change in Accured Expenses was -$8000.0 for Q1 2026 at Journey Medical, up from -$3.8 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $5.6 million in Q1 2025 and bottomed at -$5.6 million in Q2 2025.
- A 5-year average of -$390882.4 and a median of $5000.0 in 2023 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2024 — Change in Accured Expenses slumped 5506.1% — and 2025, when it jumped 10352.78%.
- Journey Medical's Change in Accured Expenses stood at $1.6 million in 2022, then plunged by 98.63% to $22000.0 in 2023, then surged by 6340.91% to $1.4 million in 2024, then sank by 366.83% to -$3.8 million in 2025, then surged by 99.79% to -$8000.0 in 2026.
- Business Quant data shows DERM's Change in Accured Expenses at -$8000.0 in Q1 2026, -$3.8 million in Q4 2025, and $3.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -144.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -234.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -12.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -14.30 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Journey Medical | 179.67 Mn | 152.45 Mn | 9.70 Mn | -8,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8,000.00 |
| Mar 31, 2026 | -8,000.00 |
| Dec 31, 2025 | -3.78 Mn |
| Dec 31, 2025 | -3.78 Mn |
| Sep 30, 2025 | 3.76 Mn |
| Sep 30, 2025 | 3.76 Mn |
| Jun 30, 2025 | -5.57 Mn |
| Jun 30, 2025 | -5.57 Mn |
| Mar 31, 2025 | 5.59 Mn |
| Mar 31, 2025 | 5.59 Mn |
| Dec 31, 2024 | 1.42 Mn |
| Dec 31, 2024 | 1.42 Mn |
| Sep 30, 2024 | 36,000.00 |
| Sep 30, 2024 | 36,000.00 |
| Jun 30, 2024 | -4.60 Mn |
| Jun 30, 2024 | -4.60 Mn |
| Mar 31, 2024 | 219,000.00 |
| Mar 31, 2024 | 219,000.00 |
| Dec 31, 2023 | 22,000.00 |
| Dec 31, 2023 | 22,000.00 |